Axa PPP removes cancer cover limits

It comes as part of the insurer's new commitment to cancer and heart disease coverage including improved treatment terms for policyholders. The provider is also waiving any monetary limits that may apply to out-patient tests and consultations for cancer patients and will offer experimental drugs when pre-agreed as part of an ethical trial. Injectable hormone treatment and bisphosphonate treatment used to manage cancer are fully covered during active treatment, while requests for experimental surgery will be considered. Heart surgery patients will also benefit from no time limits to...